Plasma phenylalanine and tyrosine and their interactions with diabetic nephropathy for risk of diabetic retinopathy in type 2 diabetes

• Published in: BMJ open diabetes research & care 2020-09, Vol.8 (1), p.e000877
• Main Authors: Luo, Hui-Huan, Li, Juan, Feng, Xiao-Fei, Sun, Xiao-Yu, Li, Jing, Yang, Xilin, Fang, Zhong-Ze
• Format: Article
• Language: English
• Subjects: Amino acids; Angina pectoris; Antihypertensives; Blood pressure; Body mass index; Cardiovascular disease; Data collection; Diabetes; Diabetic nephropathy; Diabetic retinopathy; Dopamine; Drugs; Electronic health records; Hemorrhage; Hyperglycemia; Laboratories; Lipids; Medical records; Metabolism; Metabolites; Neurodegeneration; Plasma; Risk factors; Stroke
• ISSN: 2052-4897; 2052-4897
• DOI: 10.1136/bmjdrc-2019-000877

ObjectiveTight control of hyperglycemia reduces risk of diabetic retinopathy (DR), but the residual risk remains high. This study aimed to explore relationships between plasma phenylalanine and tyrosine with DR in type 2 diabetes (T2D) and interactions between the two amino acids, and their secondary interaction with renal dysfunction.Research design and methodsWe extracted data of 1032 patients with T2D from tertiary hospital consecutively from May 2015 to August 2016. Binary logistic regression models with restricted cubic spline were used to check potential non-linear associations and to obtain ORs and 95% CIs of variables under study. Addictive interaction was estimated using relative excess risk due to interaction, attributable proportion due to interaction and synergy index. Area under the receiver operating characteristic curve was used to check increased predictive values.ResultsOf 1032 patients, 162 suffered from DR. Copresence of low phenylalanine and low tyrosine increased DR risk (OR 6.01, 95% CI 1.35 to 26.8), while either of them alone did not have a significant effect with significant additive interaction. Presence of diabetic nephropathy further increased the OR of copresence of low phenylalanine and low tyrosine for DR to 25.9 (95% CI 8.71 to 76.9) with a significant additive interaction. Inclusion of phenylalanine and tyrosine in a traditional risk factor model significantly increased area under the curve from 0.81 to 0.83 (95% CI 0.80 to 0.86).ConclusionPlasma low phenylalanine and low tyrosine worked independently and synergistically to increase the risk of DR in T2D. Presence of renal dysfunction further amplified the effect of copresence of low phenylalanine and low tyrosine on DR risk.